The stock of Diurnal Group PLC (LON:DNL) reached all time low today, Nov, 4 and still has GBX 112.14 target or 11.00% below today’s GBX 126.00 share price. This indicates more downside for the GBX 66.16 million company. This technical setup was reported by Barchart.com. If the GBX 112.14 PT is reached, the company will be worth GBX 7.28M less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only. The stock decreased 3.82% or GBX 5 on November 4, hitting GBX 126. About 17,210 shares traded hands or 342.76% up from the average. Diurnal Group PLC (LON:DNL) has declined 14.29% since April 6, 2016 and is downtrending. It has underperformed by 15.38% the S&P500.
Another recent and important Diurnal Group PLC (LON:DNL) news was published by Bioworld.com which published an article titled: “Diurnal raises $44.7M, lists on AIM, awaits Infacort phase III readout in 3rd …” on December 22, 2015.
Diurnal Group plc is a United Kingdom specialty pharmaceutical company. The company has a market cap of 66.16 million GBP. The Firm targets patient needs in chronic endocrine diseases, such as congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism and hypothyroidism. It currently has negative earnings. The Firm has two products in late-stage clinical development targeting adrenal disease: Chronocort and Infacort.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.